Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsIra M. Jacobson, David R. Nelson, Michael Bennett et al.|New England Journal of Medicine|2013Cited by 1.1k
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesMarc G. Ghany, Leonard B. Seeff, David R. Nelson et al.|Hepatology|2011Cited by 1.1k
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with RibavirinJordan J. Feld, Barry Bernstein, Kris V. Kowdley et al.|New England Journal of Medicine|2014Cited by 907
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III studyDavid R. Nelson, James N. Cooper, Jacob Lalezari et al.|Hepatology|2015Cited by 689
Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research networkRobert S. Brown, Norah A. Terrault, Jacqueline G. O’Leary et al.|Liver Transplantation|2015Cited by 105